Yang-Yin-Jie-Du decoction overcomes gefitinib resistance in non-small cell lung cancer via down-regulation of the PI3K/Akt signalling pathway
Context Yang-Yin-Jie-Du Decoction (YYJDD) was used to improve gefitinib efficacy in our clinical practice, but its mechanism remains unclear. Objective This study explored if YYJDD could reverse gefitinib resistance. Materials and methods H1975 cells were exposed to control, 10 μM gefitinib, 3.2 mg/...
Saved in:
Main Authors: | Shu-yi Chen (Author), Gao- (Author), Qi-jin Shu (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2021-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Analysis of Antidepressant Activity of Huang-Lian Jie-Du Decoction Through Network Pharmacology and Metabolomics
by: Shu-Yue Qu, et al.
Published: (2021) -
Huang-Lian Jie-Du decoction: a review on phytochemical, pharmacological and pharmacokinetic investigations
by: Yiyu Qi, et al.
Published: (2019) -
Intermodule Coupling Analysis of Huang-Lian-Jie-Du Decoction on Stroke
by: Pengqian Wang, et al.
Published: (2019) -
LINC00665 Induces Acquired Resistance to Gefitinib through Recruiting EZH2 and Activating PI3K/AKT Pathway in NSCLC
by: Xinyin Liu, et al.
Published: (2019) -
Hua-Tan-Sheng-Jing Decoction Treats Obesity With Oligoasthenozoospermia by Up-Regulating the PI3K-AKT and Down-Regulating the JNK MAPK Signaling Pathways: At the Crossroad of Obesity and Oligoasthenozoospermia
by: Yang Dong, et al.
Published: (2022)